Mobile Chat Messaging for Smoking Relapse Prevention
Effectiveness of Mobile Chat Messaging for Preventing Relapse in Smokers Who Have Recently Quit Smoking: a Randomised Controlled Trial
1 other identifier
interventional
590
1 country
2
Brief Summary
Most smokers return to smoking (relapse) after making a quit attempt, but evidence of effective intervention to prevent relapse is scarce. Taking advantage of recent advances in mobile technologies, this study aims to evaluate the effectiveness of a mobile chat messaging-based relapse prevention intervention in promoting successful quitting in people who recently quit smoking (recent abstainers) using a randomised controlled trial design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 11, 2022
CompletedStudy Start
First participant enrolled
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2025
CompletedNovember 20, 2025
April 1, 2025
1.9 years
May 6, 2022
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically validated tobacco abstinence
Verified by an exhaled carbon monoxide level of lower than 5 parts per million or a negative salivary cotinine test
6 months after randomisation
Secondary Outcomes (9)
Self-reported 6-month prolonged tobacco abstinence
6 months after randomisation
Self-reported 7-day point prevalent tobacco abstinence
3 months after randomisation
Self-reported 7-day point prevalent tobacco abstinence
6 months after randomisation
Self-reported relapse rate
3 months after randomisation
Self-reported relapse rate
6 months after randomisation
- +4 more secondary outcomes
Study Arms (2)
Mobile chat messaging
EXPERIMENTALStandard smoking cessation treatment + Personalised chat messaging
SMS messaging
ACTIVE COMPARATORStandard smoking cessation treatment + Regular SMS text messaging generic information about the harms of smoking and the benefits of quitting
Interventions
Standard smoking cessation treatment (behavioural and pharmacotherapy) provided by Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
Personalised chat messaging focusing on smoking relapse prevention for 3 months from randomisation. A trained counsellor will interact with a participant individually and provide relapse prevention advice via WhatsApp. The participant can also access a supportive chatbot in WhatsApp, which will provide on-demand smoking relapse prevention support when the counsellor is not available (e.g., during nighttime).
SMS text messaging on generic information about the harms of smoking and the benefits of quitting for 3 months from randomisation.
Eligibility Criteria
You may qualify if:
- Hong Kong residents aged 18 years or above
- Own a smartphone with WhatsApp installed
- Enrolled in a smoking cessation program under Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
- Smoked daily before the present quit attempt
- Abstained from smoking for 3 to 30 days
You may not qualify if:
- Diagnosed with a mental disease or on regular psychotropic drugs
- Participating in other ongoing smoking cessation studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
Hong Kong, Hong Kong
United Christian Nethersole Community Health Service Smoking Cessation Programme
Hong Kong, Hong Kong
Related Publications (6)
Luk TT, Wong SW, Lee JJ, Chan SS, Lam TH, Wang MP. Exploring Community Smokers' Perspectives for Developing a Chat-Based Smoking Cessation Intervention Delivered Through Mobile Instant Messaging: Qualitative Study. JMIR Mhealth Uhealth. 2019 Jan 31;7(1):e11954. doi: 10.2196/11954.
PMID: 30702431BACKGROUNDLuk TT, Li WHC, Cheung DYT, Wong SW, Kwong ACS, Lai VWY, Chan SS, Lam TH, Wang MP. Chat-based instant messaging support combined with brief smoking cessation interventions for Chinese community smokers in Hong Kong: Rationale and study protocol for a pragmatic, cluster-randomized controlled trial. Contemp Clin Trials. 2019 Feb;77:70-75. doi: 10.1016/j.cct.2018.12.013. Epub 2018 Dec 26.
PMID: 30593882BACKGROUNDWang MP, Luk TT, Wu Y, Li WH, Cheung DY, Kwong AC, Lai V, Chan SS, Lam TH. Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled trial. Lancet Digit Health. 2019 Aug;1(4):e183-e192. doi: 10.1016/S2589-7500(19)30082-2. Epub 2019 Jul 31.
PMID: 33323188BACKGROUNDLuk TT, Cheung YTD, Chan HC, Fok PW, Ho KS, Sze CD, Lam TH, Wang MP. Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2023 Jan 5;25(2):291-297. doi: 10.1093/ntr/ntac045.
PMID: 35166327BACKGROUNDLuk TT, Su X, Wong V, Chan HC, Wong GN, Lee JKH, Ho SY, Lam TH, Cheung YTD, Wang MP. Mobile Chat Messaging for Smoking Relapse Prevention: A Randomized Clinical Trial. JAMA Intern Med. 2026 Jan 20:e257439. doi: 10.1001/jamainternmed.2025.7439. Online ahead of print.
PMID: 41557345DERIVEDSu X, Wong V, Cheung YTD, Chan HC, Wong GN, Lee JKH, Ho SY, Wang MP, Luk TT. Mobile chat messaging for preventing relapse among people who recently quit smoking: Study protocol for a randomized controlled trial. Digit Health. 2024 Oct 21;10:20552076241291709. doi: 10.1177/20552076241291709. eCollection 2024 Jan-Dec.
PMID: 39439726DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tzu Tsun Luk, PhD, RN
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
May 6, 2022
First Posted
May 11, 2022
Study Start
March 14, 2023
Primary Completion
February 16, 2025
Study Completion
August 10, 2025
Last Updated
November 20, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Request to obtain IPD can be made to the principal invesitgator on reasonable request